Human Milk Antibodies Against SARS-CoV-2: A Longitudinal Follow-Up Study.

Hannah G JunckerM RomijnVeerle N LothTom G CanielsChristianne J M de GrootDasja PajkrtMarit J van GilsJohannes Hans B van GoudoeverBritt J van Keulen

Published in: Journal of human lactation : official journal of International Lactation Consultant Association (2021)

Human milk from SARS-CoV-2 convalescent lactating mothers contains specific IgA antibodies against SARS-CoV-2 spike protein up to at least 5 months post-infection. Passive viral immunity can be transferred via human milk and may serve as protection for infants against COVID-19.

Keyphrases

human milk
sars cov
low birth weight
respiratory syndrome coronavirus
preterm infants
preterm birth
coronavirus disease
heat stress
protein protein
amino acid